2019

1. Alferink LJ, Kiefte-de Jong JC, Erler NS, Veldt BJ, Schoufour JD, de Knegt RJ, Ikram MA, Metselaar HJ, Janssen H, Franco OH, Darwish Murad S. Association of Dietary Macronutrient Composition and Non-Alcoholic Fatty Liver Disease in an Ageing Population: The Rotterdam Study. Gut. 2019;68(6):1088-98.

2. Alferink LJM, Kiefte-de Jong JC, Erler NS, de Knegt RJ, Hoorn EJ, Ikram MA, Janssen HLA, Metselaar HJ, Franco OH, Darwish Murad S. Diet-Dependent Acid Load-the Missing Link between an Animal Protein-Rich Diet and Nonalcoholic Fatty Liver Disease? J Clin Endocrinol Metab. 2019;104(12):6325-37.

3. Alferink LJM, Trajanoska K, Erler NS, Schoufour JD, de Knegt RJ, Ikram MA, Janssen HLA, Franco OH, Metselaar HJ, Rivadeneira F, Darwish Murad S. Nonalcoholic Fatty Liver Disease in the Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution. J Bone Miner Res. 2019;34(7):1254-63.

4. Aronson SJ, Veron P, Collaud F, Hubert A, Delahais V, Honnet G, de Knegt RJ, Junge N, Baumann U, Di Giorgio A, D'Antiga L, Ginocchio VM, Brunetti-Pierri N, Labrune P, Beuers U, Bosma PJ, Mingozzi F. Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome. Hum Gene Ther. 2019;30(10):1297-305.

5. Beelen EMJ, de Vries AC, Bodelier AG, Moolenaar J, Schouten WR, van der Woude CJ. Isolated Ileal Blind Loop Inflammation after Intestinal Resection with Ileocolonic Anastomosis in Crohn's Disease: An Often Neglected Endoscopic Finding with an Unfavorable Outcome. Eur J Gastroenterol Hepatol. 2019;31(11):1370-5.

6. Beelen EMJ, van der Woude CJ, de Vries AC. Intestinal Resection Rates in Crohn's Disease Decline across Two Different Epidemiological Areas: A Consistent Observation Not Merely Due to Introduction of Anti-Tnfalpha. Gut. 2019.

7. Beelen EMJ, van der Woude CJ, Pierik MJ, Hoentjen F, de Boer NK, Oldenburg B, van der Meulen AE, Ponsioen CIJ, Dijkstra G, Bruggink AH, Erler NS, Schouten WR, de Vries AC, Dutch Initiative on Cs, Colitis. Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease: A Nationwide Cohort Study. Ann Surg. 2019.

8. Biemans VBC, van der Woude CJ, Dijkstra G, van der Meulen-de Jong AE, Oldenburg B, de Boer NK, Lowenberg M, Srivastava N, Bodelier AGL, West RL, Jansen JM, de Vries AC, Haans JJL, de Jong DJ, Pierik MJ, Hoentjen F. Vedolizumab for Inflammatory Bowel Disease: Two-Year Results of the Initiative on Crohn and Colitis (Icc) Registry, a Nationwide Prospective Observational Cohort Study: Icc Registry - Vedolizumab. Clin Pharmacol Ther. 2019.

9. Biondi MJ, van Tilborg M, Smookler D, Heymann G, Aquino A, Perusini S, Mandel E, Kozak RA, Cherepanov V, Kowgier M, Hansen B, Goneau LW, Janssen HLA, Mazzulli T, Cloherty G, de Knegt RJ, Feld JJ. Hepatitis C Core-Antigen Testing from Dried Blood Spots. Viruses. 2019;11(9).

10. Bleijenberg AGC, JEG IJ, Carballal S, Pellise M, Jung G, van Herwaarden YJ, Bisseling TM, Nagtegaal ID, van Leerdam ME, Spaander MCW, van Lelyveld N, Bessa X, Rodriguez-Alcalde D, Bastiaansen BAJ, de Klaver W, Bemelman WA, Bujanda L, Koornstra JJ, Rivero L, Rodriguez-Moranta F, Balaguer F, Dekker E. Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome after (Sub)Total Colectomy: Results of a 5-Year International Prospective Cohort Study. Am J Gastroenterol. 2019;114(9):1512-9.

11. Boeijen LL, Hou J, de Groen RA, Verbon A, Boonstra A. Persistent Replication of Hiv, Hepatitis C Virus (Hcv), and Hbv Results in Distinct Gene Expression Profiles by Human Nk Cells. J Virol. 2019;93(9).

12. Boeijen LL, van Oord GW, Hou J, van der Heide-Mulder M, Gaggar A, Li L, Fletcher SP, de Knegt RJ, Boonstra A. Gene Expression Profiling of Human Tissue-Resident Immune Cells: Comparing Blood and Liver. J Leukoc Biol. 2019;105(3):603-8.

13. Boor PPC, Bosma BM, Tran KTC, van der Laan LJW, Hagenaars H, JNM IJ, Metselaar HJ, Kwekkeboom J. Characterization of Antigen-Presenting Cell Subsets in Human Liver-Draining Lymph Nodes. Front Immunol. 2019;10:441.

14. Borgsteede SD, Weersink RA, Geijteman E, Metselaar HJ, Hunfeld NGM. Recommendations for Safe Medication Use in Liver Impairment: Importance of Transparency and Reflections on Analgesics, Hypnotics, and Anti-Emetics. J Pain Symptom Manage. 2019.

15. Borren NZ, Tan W, Colizzo FP, Luther J, Garber JJ, Khalili H, van der Woude CJ, Ananthakrishnan AN. Longitudinal Trajectory of Fatigue with Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study. J Crohns Colitis. 2019.

16. Borren NZ, van der Woude CJ, Ananthakrishnan AN. Fatigue in Ibd: Epidemiology, Pathophysiology and Management. Nat Rev Gastroenterol Hepatol. 2019;16(4):247-59.

17. Brand EC, Elias SG, Minderhoud IM, van der Veen JJ, Baert FJ, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Pariente B, Pierik MJ, van der Woude CJ, D'Haens G, Vermeire S, Oldenburg B, Dutch Initiative on C, Colitis. Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease. Clin Gastroenterol Hepatol. 2019.

18. Broker MEE, Taimr P, de Vries M, Braun LMM, de Man RA, Ijzermans JNM, Dwarkasing RS. Performance of Contrast-Enhanced Sonography Versus Mri with a Liver-Specific Contrast Agent for Diagnosis of Hepatocellular Adenoma and Focal Nodular Hyperplasia. AJR Am J Roentgenol. 2020;214(1):81-9.

19. Bronzwaer MES, Depla A, van Lelyveld N, Spanier BWM, Oosterhout YH, van Leerdam ME, Spaander MCW, Dekker E, Dutch Colonoscopy Quality Assurance working. Quality Assurance of Colonoscopy within the Dutch National Colorectal Cancer Screening Program. Gastrointest Endosc. 2019;89(1):1-13.

20. Brouwer WP, Chan HLY, Lampertico P, Hou J, Tangkijvanich P, Reesink HW, Zhang W, Mangia A, Tanwandee T, Montalto G, Simon K, Ormeci N, Chen L, Tabak F, Gunsar F, Flisiak R, Ferenci P, Akdogan M, Akyuz F, Hirankarn N, Jansen L, Wong VW, Soffredini R, Liang X, Chen S, Groothuismink ZMA, Santoro R, Jaroszewicz J, Ozaras R, Kozbial K, Brahmania M, Xie Q, Chotiyaputta W, Xun Q, Pazgan-Simon M, Oztas E, Verhey E, Montanari NR, Sun J, Hansen BE, Boonstra A, Janssen HLA, Consortium G-BG. Genome-Wide Association Study Identifies Genetic Variants Associated with Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The Giant-B Study. Clin Infect Dis. 2019;69(11):1969-79.

21. Bruno MJ. Pancreatic Cancer Screening - Is It Prime Time Yet? Nat Rev Gastroenterol Hepatol. 2019;16(12):709-10.

22. Bugter O, van de Ven SEM, Hardillo JA, Bruno MJ, Koch AD, Baatenburg de Jong RJ. Early Detection of Esophageal Second Primary Tumors Using Lugol Chromoendoscopy in Patients with Head and Neck Cancer: A Systematic Review and Meta-Analysis. Head Neck. 2019;41(4):1122-30.

23. Campos S, Poley JW, van Driel L, Bruno MJ. The Role of Eus in Diagnosis and Treatment of Liver Disorders. Endosc Int Open. 2019;7(10):E1262-E75.

24. Chen K, Sheng J, Ma B, Cao W, Hernanda PY, Liu J, Boor PPC, Tjon ASW, Felczak K, Sprengers D, Pankiewicz KW, Metselaar HJ, Ma Z, Kwekkeboom J, Peppelenbosch MP, Pan Q. Suppression of Hepatocellular Carcinoma by Mycophenolic Acid in Experimental Models and in Patients. Transplantation. 2019;103(5):929-37.

25. Cheung AC, Lammers WJ, Murillo Perez CF, van Buuren HR, Gulamhusein A, Trivedi PJ, Lazaridis KN, Ponsioen CY, Floreani A, Hirschfield GM, Corpechot C, Mayo MJ, Invernizzi P, Battezzati PM, Pares A, Nevens F, Thorburn D, Mason AL, Carbone M, Kowdley KV, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lindor KD, Lleo A, Poupon R, Janssen HLA, Hansen BE, Global PBCSG. Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-Free Survival in Patients with Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2019;17(10):2076-84 e2.

26. Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen BE, Janssen HLA, Patel K. Nonalcoholic Steatohepatitis Is Associated with Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B. Hepatology. 2019.

27. Corral JE, Das A, Bruno MJ, Wallace MB. Cost-Effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis. Pancreas. 2019;48(4):526-36.

28. Das T, Bergen IM, Koudstaal T, van Hulst JAC, van Loo G, Boonstra A, Vanwolleghem T, Leung PSC, Gershwin ME, Hendriks RW, Kool M. Dngr1-Mediated Deletion of A20/Tnfaip3 in Dendritic Cells Alters T and B-Cell Homeostasis and Promotes Autoimmune Liver Pathology. J Autoimmun. 2019;102:167-78.

29. de Beijer MTA, Jansen D, Dou Y, van Esch WJE, Mok JY, Maas MJP, Brasser G, de Man RA, Woltman AM, Buschow SI. Discovery and Selection of Hbv-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation and Hla-Binding Strength. J Virol. 2019.

30. de Boer JD, Blok JJ, Putter H, Koopman JJE, van Hoek B, Samuel U, van Rosmalen M, Metselaar HJ, Alwayn IPJ, Guba M, Braat AE, Eurotransplant L, Intestine Advisory C. Optimizing the Use of Geriatric Livers for Transplantation in the Eurotransplant Region. Liver Transpl. 2019;25(2):260-74.

31. de Jong W, de Man RA, Dalm V, Reusken C, Goeijenbier M, van Gorp ECM. Yellow Fever Vaccination for Immunocompromised Travellers: Unjustified Vaccination Hesitancy? J Travel Med. 2019;26(6).

32. de Klerk CM, Wieten E, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MCW, Dekker E. Participation and Ease of Use in Colorectal Cancer Screening: A Comparison of 2 Fecal Immunochemical Tests. Am J Gastroenterol. 2019;114(3):511-8.

33. Debes JD, Boonstra A, Balderramo D, Mattos AZ, Arrese M, investigators E. Hepatobiliary Cancers in South America: Disparity Strikes. Lancet Gastroenterol Hepatol. 2019;4(8):581.

34. Debes JD, Carrera E, Mattos AZ, Prieto JE, Boonstra A, investigators E. Hepatocellular Carcinoma, a Unique Tumor with a Lack of Biomarkers. Ann Hepatol. 2019;18(6):786-7.

35. Debes JD, Groothuismink ZMA, Doukas M, de Man RA, Boonstra A. Immune Dissociation During Acute Hepatitis E Infection. Int J Infect Dis. 2019;87:39-42.

36. den Hollander WJ, Holster IL, den Hoed CM, Capelle LG, Tang TJ, Anten MP, Prytz-Berset I, Witteman EM, Ter Borg F, Hartog GD, Bruno MJ, Peppelenbosch MP, Lesterhuis W, Doukas M, Kuipers EJ, Spaander MCW. Surveillance of Premalignant Gastric Lesions: A Multicentre Prospective Cohort Study from Low Incidence Regions. Gut. 2019;68(4):585-93.

37. Detillon D, Aarts MJ, De Jaeger K, Van Eijck CHJ, Veen EJ. Video-Assisted Thoracic Lobectomy Versus Stereotactic Body Radiotherapy for Stage I Nonsmall Cell Lung Cancer in Elderly Patients: A Propensity Matched Comparative Analysis. Eur Respir J. 2019;53(6).

38. Detillon D, van Eijck CHJ, Veen EJ. [Is Surgical Treatment of Pulmonary Metastases Justified? Resectie Van Longmetastasen Gerechtvaardigd?  Ned Tijdschr Geneeskd. 2019;163.

39. Deuring JJ, Li M, Cao W, Chen S, Wang W, de Haar C, van der Woude CJ, Peppelenbosch M. Pregnane X Receptor Activation Constrains Mucosal Nf-Kappab Activity in Active Inflammatory Bowel Disease. PLoS One. 2019;14(10):e0221924.

40. Dou Y, van Montfoort N, van den Bosch A, Janssen HLA, de Man RA, Buschow SI, Woltman AM. Elevated Serum Levels of Soluble Cd14 in Hbeag-Positive Chronic Hbv Patients Upon Peginterferon Treatment Are Associated with Treatment Response. J Viral Hepat. 2019;26(9):1076-85.

41. Dreesen E, Baert F, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Oldenburg B, Pariente B, Pierik M, van der Woude CJ, D'Haens G, Vermeire S, Gils A. Monitoring a Combination of Calprotectin and Infliximab Identifies Patients with Mucosal Healing of Crohn's Disease. Clin Gastroenterol Hepatol. 2019.

42. Duizendstra AA, de Knegt RJ, Betjes MGH, Coenen S, Murad SD, de Man RA, Metselaar HJ, Sprengers D, Litjens NHR, Kwekkeboom J. Immunosuppressive Drug Withdrawal Late after Liver Transplantation Improves the Lipid Profile and Reduces Infections. Eur J Gastroenterol Hepatol. 2019;31(11):1444-51.

43. Dulfer RR, Koh EY, van der Plas WY, Engelsman AF, van Dijkum E, Pol RA, Vogt L, de Borst MH, Kruijff S, Schepers A, Appelman-Dijkstra NM, Rotmans JI, Hesselink DA, van Eijck CHJ, Hoorn EJ, van Ginhoven TM, Dutch Hyperparathyroid Study G. Parathyroidectomy Versus Cinacalcet for Tertiary Hyperparathyroidism; a Retrospective Analysis. Langenbecks Arch Surg. 2019;404(1):71-9.

44. Epskamp C, van Eijck CHJ, Sinke R, Hamberg P. "Duodenal Adenocarcinoma Giving Rise to Rectal Metastasis" a Rare Disease with an Extremely Rare Metastatic Pattern. J Gastrointest Cancer. 2019;50(3):586-8.

45. Faria AVS, Akyala AI, Parikh K, Bruggemann LW, Spek CA, Cao W, Bruno MJ, Bijlsma MF, Fuhler GM, Peppelenbosch MP. Smoothened-Dependent and -Independent Pathways in Mammalian Noncanonical Hedgehog Signaling. J Biol Chem. 2019;294(25):9787-98.

46. Faria AVS, Andrade SS, Reijm AN, Spaander MCW, de Maat MPM, Peppelenbosch MP, Ferreira-Halder CV, Fuhler GM. Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J Clin Med. 2019;8(7).

47. Fest J, Ruiter R, Mooijaart SP, Ikram MA, van Eijck CHJ, Stricker BH. Erythrocyte Sedimentation Rate as an Independent Prognostic Marker for Mortality: A Prospective Population-Based Cohort Study. J Intern Med. 2019;285(3):341-8.

48. Fest J, Ruiter R, Mulder M, Groot Koerkamp B, Ikram MA, Stricker BH, van Eijck CHJ. The Systemic Immune-Inflammation Index Is Associated with an Increased Risk of Incident Cancer-a Population-Based Cohort Study. Int J Cancer. 2020;146(3):692-8.

49. Fest J, Ruiter TR, Groot Koerkamp B, Rizopoulos D, Ikram MA, van Eijck CHJ, Stricker BH. The Neutrophil-to-Lymphocyte Ratio Is Associated with Mortality in the General Population: The Rotterdam Study. Eur J Epidemiol. 2019;34(5):463-70.

50. Fest J, Vijfhuizen LS, Goeman JJ, Veth O, Joensuu A, Perola M, Mannisto S, Ness-Jensen E, Hveem K, Haller T, Tonisson N, Mikkel K, Metspalu A, van Duijn CM, Ikram A, Stricker BH, Ruiter R, van Eijck CHJ, van Ommen GB, t Hoen PAC. Search for Early Pancreatic Cancer Blood Biomarkers in Five European Prospective Population Biobanks Using Metabolomics. Endocrinology. 2019;160(7):1731-42.

51. Gaspersz MP, Klompenhouwer AJ, Broker MEE, Thomeer MGJ, van Aalten SM, Steegers E, Terkivatan T, de Koning H, de Man RA, Ijzermans JNM. Growth of Hepatocellular Adenoma During Pregnancy: A Prospective Study. J Hepatol. 2020;72(1):119-24.

52. Gatselis NK, Goet JC, Zachou K, Lammers WJ, Janssen HLA, Hirschfield G, Corpechot C, Lindor KD, Invernizzi P, Mayo MJ, Battezzati PM, Floreani A, Pares A, Lygoura V, Nevens F, Mason AL, Kowdley KV, Ponsioen CY, Bruns T, Thorburn D, Verhelst X, Harms MH, van Buuren HR, Hansen BE, Dalekos GN, Global Primary Biliary Cholangitis Study G. Factors Associated with Progression and Outcomes of Early Stage Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2019.

53. Ghalandari N, Dolhain R, Hazes JMW, Siezen CLE, van der Laan JW, Crijns H, van Puijenbroek EP, van der Woude CJ. The Pre- and Post-Authorisation Data Published by the European Medicines Agency on the Use of Biologics During Pregnancy and Lactation. Br J Clin Pharmacol. 2019.

54. Goet JC, Beelen EMJ, Biermann KE, Gijsbers AH, Schouten WR, van der Woude CJ, de Vries AC. Cholecystectomy Risk in Crohn's Disease Patients after Ileal Resection: A Long-Term Nationwide Cohort Study. J Gastrointest Surg. 2019;23(9):1840-7.

55. Goet JC, Floreani A, Verhelst X, Cazzagon N, Perini L, Lammers WJ, de Vries AC, van der Meer AJ, van Buuren HR, Hansen BE. Validation, Clinical Utility and Limitations of the Amsterdam-Oxford Model for Primary Sclerosing Cholangitis. J Hepatol. 2019;71(5):992-9.

56. Goetgebuer RL, van der Woude CJ, de Ridder L, Doukas M, de Vries AC. Clinical and Endoscopic Complications of Epstein-Barr Virus in Inflammatory Bowel Disease: An Illustrative Case Series. Int J Colorectal Dis. 2019;34(5):923-6.

57. Gotink AW, Ten Kate FJ, Doukas M, Wijnhoven BP, Bruno MJ, Looijenga LH, Koch AD, Biermann K. Do Pathologists Agree with Each Other on the Histological Assessment of Pt1b Oesophageal Adenocarcinoma? United European Gastroenterol J. 2019;7(2):261-9.

58. Goverde A, Eikenboom EL, Viskil EL, Bruno MJ, Doukas M, Dinjens WNM, Dubbink HJ, van den Ouweland AMW, Hofstra RMW, Wagner A, Spaander MCW. Yield of Lynch Syndrome Surveillance for Patients with Pathogenic Variants in DNA Mismatch Repair Genes. Clin Gastroenterol Hepatol. 2019.

59. Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, Bossuyt PMM, Kuipers EJ, Dekker E, Spaander MCW. Diagnostic Yield of One-Time Colonoscopy Vs One-Time Flexible Sigmoidoscopy Vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening. Clin Gastroenterol Hepatol. 2019.

60. Grootjans J, Krupka N, Hosomi S, Matute JD, Hanley T, Saveljeva S, Gensollen T, Heijmans J, Li H, Limenitakis JP, Ganal-Vonarburg SC, Suo S, Luoma AM, Shimodaira Y, Duan J, Shih DQ, Conner ME, Glickman JN, Fuhler GM, Palm NW, de Zoete MR, van der Woude CJ, Yuan GC, Wucherpfennig KW, Targan SR, Rosenstiel P, Flavell RA, McCoy KD, Macpherson AJ, Kaser A, Blumberg RS. Epithelial Endoplasmic Reticulum Stress Orchestrates a Protective Iga Response. Science. 2019;363(6430):993-8.

61. Hamade N, Vennelaganti S, Parasa S, Vennalaganti P, Gaddam S, Spaander MCW, van Olphen SH, Thota PN, Kennedy KF, Bruno MJ, Vargo JJ, Mathur S, Cash BD, Sampliner R, Gupta N, Falk GW, Bansal A, Young PE, Lieberman DA, Sharma P. Lower Annual Rate of Progression of Short-Segment Vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol. 2019;17(5):864-8.

62. Harms MH, van Buuren HR, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Hirschfield GM, Pares A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Lammers WJ, Hansen BE, van der Meer AJ. Ursodeoxycholic Acid Therapy and Liver Transplant-Free Survival in Patients with Primary Biliary Cholangitis. J Hepatol. 2019;71(2):357-65.

63. Harms MH, van Buuren HR, Hansen BE, Metselaar HJ. Editorial: Liver Transplantation for Primary Biliary Cholangitis-the Need for Timely and More Effective Treatments. Authors' Reply. Aliment Pharmacol Ther. 2019;49(4):473-4.

64. Hollemans RA, Bakker OJ, Boermeester MA, Bollen TL, Bosscha K, Bruno MJ, Buskens E, Dejong CH, van Duijvendijk P, van Eijck CH, Fockens P, van Goor H, van Grevenstein WM, van der Harst E, Heisterkamp J, Hesselink EJ, Hofker S, Houdijk AP, Karsten T, Kruyt PM, van Laarhoven CJ, Lameris JS, van Leeuwen MS, Manusama ER, Molenaar IQ, Nieuwenhuijs VB, van Ramshorst B, Roos D, Rosman C, Schaapherder AF, van der Schelling GP, Timmer R, Verdonk RC, de Wit RJ, Gooszen HG, Besselink MG, van Santvoort HC, Dutch Pancreatitis Study G. Superiority of Step-up Approach Vs Open Necrosectomy in Long-Term Follow-up of Patients with Necrotizing Pancreatitis. Gastroenterology. 2019;156(4):1016-26.

65. Hoogeveen RC, Robidoux MP, Schwarz T, Heydmann L, Cheney JA, Kvistad D, Aneja J, Melgaco JG, Fernandes CA, Chung RT, Boonstra A, Kim AY, Baumert TF, Timm J, Lewis-Ximenez LL, Tonnerre P, Lauer GM. Phenotype and Function of Hbv-Specific T Cells Is Determined by the Targeted Epitope in Addition to the Stage of Infection. Gut. 2019;68(5):893-904.

66. Janmaat VT, Liu H, da Silva RA, Wisse PHA, Spaander MCW, Ten Hagen TLM, Smits R, Bruno MJ, Fuhler GM, Peppelenbosch MP. Hoxa9 Mediates and Marks Premalignant Compartment Size Expansion in Colonic Adenomas. Carcinogenesis. 2019;40(12):1514-24.

67. Kamar N, Abravanel F, Behrendt P, Hofmann J, Pageaux GP, Barbet C, Moal V, Couzi L, Horvatits T, De Man RA, Cassuto E, Elsharkawy AM, Riezebos-Brilman A, Scemla A, Hillaire S, Donnelly MC, Radenne S, Sayegh J, Garrouste C, Dumortier J, Glowaki F, Matignon M, Coilly A, Figueres L, Mousson C, Minello A, Dharancy S, Rerolle JP, Lebray P, Etienne I, Perrin P, Choi M, Marion O, Izopet J, Hepatitis EVRSG. Ribavirin for Hepatitis E Virus Infection after Organ Transplantation: A Large European Retrospective Multicenter Study. Clin Infect Dis. 2019.

68. Kappelle WF, van Hooft JE, Spaander MCW, Vleggaar FP, Bruno MJ, Maluf-Filho F, Bogte A, van Halsema E, Siersema PD. Treatment of Refractory Post-Esophagectomy Anastomotic Esophageal Strictures Using Temporary Fully Covered Esophageal Metal Stenting Compared to Repeated Bougie Dilation: Results of a Randomized Controlled Trial. Endosc Int Open. 2019;7(2):E178-E85.

69. Klompenhouwer AJ, Alblas M, van Rosmalen BV, Haring MPD, Venema E, Doukas M, Thomeer MGJ, Takkenberg RB, Verheij J, de Meijer VE, van Gulik TM, Lingsma HF, de Man RA, Ijzermans JNM. Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma. Am J Gastroenterol. 2019;114(8):1292-8.

70. Klompenhouwer AJ, Dwarkasing RS, Doukas M, Pellegrino S, Vilgrain V, Paradis V, Soubrane O, Beane JD, Geller DA, Nalesnik MA, Tripke V, Lang H, Schmelzle M, Pratschke J, Schoning W, Beal E, Sun S, Pawlik TM, de Man RA, Ijzermans JNM. Hepatic Angiomyolipoma: An International Multicenter Analysis on Diagnosis, Management and Outcome. HPB (Oxford). 2019.

71. Klompenhouwer AJ, Ten Cate DWG, Willemssen F, Bramer WM, Doukas M, de Man RA, Ijzermans JNM. The Impact of Imaging on the Surgical Management of Biliary Cystadenomas and Cystadenocarcinomas; a Systematic Review. HPB (Oxford). 2019;21(10):1257-67.

72. Klompenhouwer AJ, Thomeer MGJ, Dinjens WNM, de Man RA, Ijzermans JNM, Doukas M. Phenotype or Genotype: Decision-Making Dilemmas in Hepatocellular Adenoma. Hepatology. 2019;70(5):1866-8.

73. Konings I, Canto MI, Almario JA, Harinck F, Saxena P, Lucas AL, Kastrinos F, Whitcomb DC, Brand RE, Lachter J, Malleo G, Paiella S, Syngal S, Saltzman JR, Stoffel EM, van Hooft JE, Hruban RH, Poley JW, Fockens P, Goggins MG, Bruno MJ, International CotPSC. Surveillance for Pancreatic Cancer in High-Risk Individuals. BJS Open. 2019;3(5):656-65.

74. Kooyker AI, Toes-Zoutendijk E, Opstal-van Winden AWJ, Spaander MCW, Buskermolen M, van Vuuren HJ, Kuipers EJ, van Kemenade FJ, Ramakers C, Thomeer MGJ, Dekker E, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I. The Second Round of the Dutch Colorectal Cancer Screening Program: Impact of an Increased Fecal Immunochemical Test Cut-Off Level on Yield of Screening. Int J Cancer. 2019.

75. Kreijne JE, de Veer RC, de Boer NK, Dijkstra G, West R, Moorsel SAW, de Jong DJ, van der Woude CJ, de Vries AC, of the Dutch Initiative on Crohn C. Real-Life Study of Safety of Thiopurine-Allopurinol Combination Therapy in Inflammatory Bowel Disease: Myelotoxicity and Hepatotoxicity Rarely Affect Maintenance Treatment. Aliment Pharmacol Ther. 2019;50(4):407-15.

76. Kreijne JE, van der Giessen J, Verhaar AP, Peppelenbosch MP, de Vries AC, van der Woude CJ, Fuhler GM. Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease. J Clin Gastroenterol. 2019;53(5):395-7.

77. Labeur TA, Berhane S, Edeline J, Blanc JF, Bettinger D, Meyer T, Van Vugt JLA, Ten Cate DWG, De Man RA, Eskens F, Cucchetti A, Bonnett LJ, Van Delden OM, Klumpen HJ, Takkenberg RB, Johnson PJ. Improved Survival Prediction and Comparison of Prognostic Models for Patients with Hepatocellular Carcinoma Treated with Sorafenib. Liver Int. 2020;40(1):215-28.

78. Labeur TA, van Vugt JLA, Ten Cate DWG, Takkenberg RB, JNM IJ, Groot Koerkamp B, de Man RA, van Delden OM, Eskens F, Klumpen HJ. Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib. Liver Cancer. 2019;8(4):255-70.

79. Lakhtakia S, Reddy N, Dolak W, Ponchon T, Bruno MJ, Bourke MJ, Neuhaus H, Roy A, Gonzalez-Huix Llado F, Kortan PP, Peetermans J, Rousseau M, Costamagna G, Deviere J, Benign Biliary Stenoses Working G. Long-Term Outcomes after Temporary Placement of a Self-Expanding Fully Covered Metal Stent for Benign Biliary Strictures Secondary to Chronic Pancreatitis. Gastrointest Endosc. 2019.

80. Latenstein AEJ, van der Geest LGM, Bonsing BA, Groot Koerkamp B, Haj Mohammad N, de Hingh I, de Meijer VE, Molenaar IQ, van Santvoort HC, van Tienhoven G, Verheij J, Vissers PAJ, de Vos-Geelen J, Busch OR, van Eijck CHJ, van Laarhoven HWM, Besselink MG, Wilmink JW, Dutch Pancreatic Cancer G. Nationwide Trends in Incidence, Treatment and Survival of Pancreatic Ductal Adenocarcinoma. Eur J Cancer. 2020;125:83-93.

81. Leathers JS, Pisano MB, Re V, Van Oord G, Sultan A, Boonstra A, Debes JD. Evaluation of Rapid Diagnostic Tests for Assessment of Hepatitis B in Resource-Limited Settings. Ann Glob Health. 2019;85(1).

82. Leathers JS, Pisano MB, Re V, van Oord G, Sultan A, Boonstra A, Debes JD. Validation of a Point-of-Care Rapid Diagnostic Test for Hepatitis C for Use in Resource-Limited Settings. Int Health. 2019;11(4):314-5.

83. Linnemann RJA, Patijn GA, van Rijssen LB, Besselink MG, Mungroop TH, de Hingh IH, Kazemier G, Festen S, de Jong KP, van Eijck CHJ, Scheepers JJG, van der Kolk M, Dulk MD, Bosscha K, Busch OR, Boerma D, van der Harst E, Nieuwenhuijs VB, Dutch Pancreatic Cancer G. The Role of Abdominal Drainage in Pancreatic Resection - a Multicenter Validation Study for Early Drain Removal. Pancreatology. 2019;19(6):888-96.

84. Lowenberg M, Vermeire S, Mostafavi N, Hoentjen F, Franchimont D, Bossuyt P, Hindryckx P, Rispens T, de Vries A, van der Woude CJ, Berends S, Ambarus CA, Mathot R, Clasquin E, Baert F, D'Haens G. Vedolizumab Induces Endoscopic and Histologic Remission in Patients with Crohn's Disease. Gastroenterology. 2019;157(4):997-1006 e6.

85. Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, van der Woude CJ, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK, International Primary Sclerosing Cholangitis Study G, Levy C. Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020;18(1):179-87 e6.

86. Mackay TM, Smits FJ, Roos D, Bonsing BA, Bosscha K, Busch OR, Creemers GJ, van Dam RM, van Eijck CHJ, Gerhards MF, de Groot JWB, Groot Koerkamp B, Haj Mohammad N, van der Harst E, de Hingh I, Homs MYV, Kazemier G, Liem MSL, de Meijer VE, Molenaar IQ, Nieuwenhuijs VB, van Santvoort HC, van der Schelling GP, Stommel MWJ, Ten Tije AJ, de Vos-Geelen J, Wit F, Wilmink JW, van Laarhoven HWM, Besselink MG, Dutch Pancreatic Cancer G. The Risk of Not Receiving Adjuvant Chemotherapy after Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Analysis. HPB (Oxford). 2019.

87. Minnee RC, Darwish Murad S, Polak WG, Metselaar HJ. Combined Liver-Kidney Transplantation: Two for the Price of One? Transpl Int. 2019;32(9):913-5.

88. Mueller-Breckenridge AJ, Garcia-Alcalde F, Wildum S, Smits SL, de Man RA, van Campenhout MJH, Brouwer WP, Niu J, Young JAT, Najera I, Zhu L, Wu D, Racek T, Hundie GB, Lin Y, Boucher CA, van de Vijver D, Haagmans BL. Machine-Learning Based Patient Classification Using Hepatitis B Virus Full-Length Genome Quasispecies from Asian and European Cohorts. Sci Rep. 2019;9(1):18892.

89. Muthusamy VR, Bruno MJ, Kozarek RA, Petersen BT, Pleskow DK, Sejpal DV, Slivka A, Peetermans JA, Rousseau MJ, Tirrell GP, Ross AS. Clinical Evaluation of a Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography. Clin Gastroenterol Hepatol. 2019.

90. Nesteruk K, Spaander MCW, Leeuwenburgh I, Peppelenbosch MP, Fuhler GM. Achalasia and Associated Esophageal Cancer Risk: What Lessons Can We Learn from the Molecular Analysis of Barrett's-Associated Adenocarcinoma? Biochim Biophys Acta Rev Cancer. 2019;1872(2).

91. Nieuwenburg SAV, Vuik FER, Kruip M, Kuipers EJ, Spaander MCW. Effect of Anticoagulants and Nsaids on Accuracy of Faecal Immunochemical Tests (Fits) in Colorectal Cancer Screening: A Systematic Review and Meta-Analysis. Gut. 2019;68(5):866-72.

92. Nieuwenburg SAV, Waddingham WW, Graham D, Rodriguez-Justo M, Biermann K, Kuipers EJ, Banks M, Jansen M, Spaander MCW. Accuracy of Endoscopic Staging and Targeted Biopsies for Routine Gastric Intestinal Metaplasia and Gastric Atrophy Evaluation Study Protocol of a Prospective, Cohort Study: The Estimate Study. BMJ Open. 2019;9(9):e032013.

93. Oey RC, Buck LEM, Erler NS, van Buuren HR, de Man RA. The Efficacy and Safety of Rifaximin-Alpha: A 2-Year Observational Study of Overt Hepatic Encephalopathy. Therap Adv Gastroenterol. 2019;12:1756284819858256.

94. Oey RC, Spaander MCW, van Buuren HR, de Man RA. Reply. Hepatology. 2019;70(5):1875-6.

95. Oey RC, van Tilburg L, Erler NS, Metselaar HJ, Spaander MCW, van Buuren HR, de Man RA. The Yield and Safety of Screening Colonoscopy in Patients Evaluated for Liver Transplantation. Hepatology. 2019;69(6):2598-607.

96. Overbeek KA, Alblas M, Gausman V, Kandel P, Schweber AB, Brooks C, Van Riet PA, Wallace MB, Gonda TA, Cahen DL, Bruno MJ. Development of a Stratification Tool to Identify Pancreatic Intraductal Papillary Mucinous Neoplasms at Lowest Risk of Progression. Aliment Pharmacol Ther. 2019;50(7):789-99.

97. Overbeek KA, Cahen DL, Bruno MJ. Editorial: When, Who and How-the Ever-Evolving Management of Pancreatic Cystic Lesions. Authors' Reply. Aliment Pharmacol Ther. 2019;50(7):829-30.

98. Overbeek KA, Kamps A, van Riet PA, Di Marco M, Zerboni G, van Hooft JE, Carrara S, Ricci C, Gonda TA, Schoon E, Polkowski M, Beyer G, Honkoop P, van der Waaij LA, Casadei R, Capurso G, Erler NS, Bruno MJ, Bleiker EMA, Cahen DL, group Ps. Pancreatic Cyst Surveillance Imposes Low Psychological Burden. Pancreatology. 2019;19(8):1061-6.

99. Pauwels RWM, de Vries AC, van der Woude CJ. Comment on "Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease". Inflamm Bowel Dis. 2019;25(5):e59.

100. Peters CP, den Hoed CM, Coenen S, Biermann KE, de Man RA. [Acute Liver Failure Due to Food Supplements] Acuut Leverfalen Na Gebruik Van Voedingssupplementen. Ned Tijdschr Geneeskd. 2019;163.

101. Peterse EFP, Naber SK, Daly C, Pollett A, Paszat LF, Spaander MCW, Aronson M, Gryfe R, Rabeneck L, Lansdorp-Vogelaar I, Baxter NN. Cost-Effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome Cases. Clin Gastroenterol Hepatol. 2019.

102. Phan MV, Murad SD, van der Eijk AA, Metselaar HJ, Hartog H, Harinck F, GeurtsvanKessel CH, Molenkamp R, Cotten M, Koopmans MP. Genomic Sequence of Yellow Fever Virus from a Dutch Traveller Returning from the Gambia-Senegal Region, the Netherlands, November 2018. Euro Surveill. 2019;24(4).

103. Popping S, Hullegie SJ, Boerekamps A, Rijnders BJA, de Knegt RJ, Rockstroh JK, Verbon A, Boucher CAB, Nichols BE, van de Vijver D. Early Treatment of Acute Hepatitis C Infection Is Cost-Effective in Hiv-Infected Men-Who-Have-Sex-with-Men. PLoS One. 2019;14(1):e0210179.

104. Qu C, Li Y, Li Y, Yu P, Li P, Donkers JM, van de Graaf SFJ, de Man RA, Peppelenbosch MP, Pan Q. Fda-Drug Screening Identifies Deptropine Inhibiting Hepatitis E Virus Involving the Nf-Kappab-Ripk1-Caspase Axis. Antiviral Res. 2019;170:104588.

105. Quispel R, van Driel L, Honkoop P, Hadithi M, Anten MP, Smedts F, Kerkmeer MC, Veldt BJ, Bruno MJ, Dutch RRQiET. Collaboration of Community Hospital Endosonographers Improves Diagnostic Yield of Endoscopic Ultrasonography Guided Tissue Acquisition of Solid Pancreatic Lesions. Endosc Int Open. 2019;7(6):E800-E7.

106. Rauwers AW, Troelstra A, Fluit AC, Wissink C, Loeve AJ, Vleggaar FP, Bruno MJ, Vos MC, Bode LG, Monkelbaan JF. Independent Root-Cause Analysis of Contributing Factors, Including Dismantling of 2 Duodenoscopes, to Investigate an Outbreak of Multidrug-Resistant Klebsiella Pneumoniae. Gastrointest Endosc. 2019;90(5):793-804.

107. Reijm AN, Didden P, Schelling SJC, Siersema PD, Bruno MJ, Spaander MCW. Self-Expandable Metal Stent Placement for Malignant Esophageal Strictures - Changes in Clinical Outcomes over Time. Endoscopy. 2019;51(1):18-29.

108. Rigter LS, Spaander MCW, Aleman BMP, Bisseling TM, Moons LM, Cats A, Lugtenburg PJ, Janus CPM, Petersen EJ, Roesink JM, van der Maazen RWM, Snaebjornsson P, Kuipers EJ, Bruno MJ, Dekker E, Meijer GA, de Boer JP, van Leeuwen FE, van Leerdam ME. High Prevalence of Advanced Colorectal Neoplasia and Serrated Polyposis Syndrome in Hodgkin Lymphoma Survivors. Cancer. 2019;125(6):990-9.

109. Ross AS, Bruno MJ, Kozarek RA, Petersen BT, Pleskow DK, Sejpal DV, Slivka A, Moore D, Panduro K, Peetermans JA, Insull J, Rousseau MJ, Tirrell GP, Muthusamy VR. Novel Single-Use Duodenoscope Compared with 3 Models of Reusable Duodenoscopes for Ercp: A Randomized Bench-Model Comparison. Gastrointest Endosc. 2019.

110. Roumans CAM, van der Bogt RD, Steyerberg EW, Rizopoulos D, Lansdorp-Vogelaar I, Sharma P, Spaander MCW, Bruno MJ. Adherence to Recommendations of Barrett's Esophagus Surveillance Guidelines: A Systematic Review and Meta-Analysis. Endoscopy. 2020;52(1):17-28.

111. Sahar N, Ross A, Lakhtakia S, Cote GA, Neuhaus H, Bruno MJ, Haluszka O, Kozarek R, Ramchandani M, Beyna T, Poley JW, Maranki J, Freeman M, Kedia P, Tarnasky P, Pancreatic Stenting Registry G. Reducing the Risk of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Fr Pancreatic Plastic Stents Placed with Common-Type Guidewires: Results from a Prospective Multinational Registry. Dig Endosc. 2019;31(3):299-306.

112. Sari G, van de Garde MDB, van Schoonhoven A, Voermans JJC, van der Eijk AA, de Man RA, Boonstra A, Vanwolleghem T, Pas SD. Hepatitis E Virus Shows More Genomic Alterations in Cell Culture Than in Vivo. Pathogens. 2019;8(4).

113. Schepers NJ, Bakker OJ, Besselink MG, Ahmed Ali U, Bollen TL, Gooszen HG, van Santvoort HC, Bruno MJ, Dutch Pancreatitis Study G. Impact of Characteristics of Organ Failure and Infected Necrosis on Mortality in Necrotising Pancreatitis. Gut. 2019;68(6):1044-51.

114. Schreuders EH, Grobbee EJ, Nieuwenburg SAV, Kapidzic A, van Roon AHC, van Vuuren AJ, Lansdorp-Vogelaar I, Spijker WWJ, Izelaar K, Bruno MJ, Kuipers EJ, Spaander MCW. Multiple Rounds of One Sample Versus Two Sample Faecal Immunochemical Test-Based Colorectal Cancer Screening: A Population-Based Study. Lancet Gastroenterol Hepatol. 2019;4(8):622-31.

115. Shah SM, Baniya JB, Gupta BP, Shrestha A, Rodin H, Boonstra A, Debes JD. Short Article: Association between Liver Fibrosis and Hepatitis E Seroprevalence among Hiv-Positive Individuals in Nepal. Eur J Gastroenterol Hepatol. 2019;31(4):503-5.

116. Shen S, Wong GL, Kuang Z, van Campenhout MJH, Fan R, Wong VW, Yip TC, Chi H, Liang X, Hu X, Lin W, Wu Y, Liu X, Boonstra A, Hou J, Sun J, Chan HL. Development and Validation of a Model for Hepatitis B E Antigen Seroconversion in Entecavir-Treated Patients with Chronic Hepatitis B. J Med Virol. 2019.

117. Sideras K, de Man RA, Harrington SM, Polak WG, Zhou G, Schutz HM, Pedroza-Gonzalez A, Biermann K, Mancham S, Hansen BE, Bart Takkenberg R, van Vuuren AJ, Pan Q, Ijzermans JNM, Sleijfer S, Sprengers D, Dong H, Kwekkeboom J, Bruno MJ. Circulating Levels of Pd-L1 and Galectin-9 Are Associated with Patient Survival in Surgically Treated Hepatocellular Carcinoma Independent of Their Intra-Tumoral Expression Levels. Sci Rep. 2019;9(1):10677.

118. Simsek M, Lissenberg-Witte BI, van Riswijk MLM, Verschuren S, Hoentjen F, Oldenburg B, Ponsioen CY, van der Woude CJ, van der Meulen AE, Pierik M, Dijkstra G, de Boer NKH, Parelsnoer Institute tDIoCs, Colitis. Off-Label Prescriptions of Drugs Used for the Treatment of Crohn's Disease or Ulcerative Colitis. Aliment Pharmacol Ther. 2019;49(10):1293-300.

119. Smits FJ, Molenaar IQ, Besselink MG, Borel Rinkes IHM, van Eijck CHJ, Busch OR, van Santvoort HC, Dutch Pancreatic Cancer G. Early Recognition of Clinically Relevant Postoperative Pancreatic Fistula: A Systematic Review. HPB (Oxford). 2019.

120. Soares E, Groothuismink ZMA, Boonstra A, Borges O. Glucan Particles Are a Powerful Adjuvant for the Hbsag, Favoring Antiviral Immunity. Mol Pharm. 2019;16(5):1971-81.

121. Sonneveld MJ, Brouwer WP, Chan HL, Piratvisuth T, Jia JD, Zeuzem S, Liaw YF, Hansen BE, Choi H, Wat C, Pavlovic V, Gaggar A, Xie Q, Buti M, de Knegt RJ, Janssen HLA. Optimisation of the Use of Apri and Fib-4 to Rule out Cirrhosis in Patients with Chronic Hepatitis B: Results from the Sonic-B Study. Lancet Gastroenterol Hepatol. 2019;4(7):538-44.

122. Sonneveld MJ, van Oord GW, van Campenhout MJ, De Man RA, Janssen HLA, de Knegt RJ, Boonstra A, van der Eijk AA. Relationship between Hepatitis B Core-Related Antigen Levels and Sustained Hbeag Seroconversion in Patients Treated with Nucleo(S)Tide Analogues. J Viral Hepat. 2019;26(7):828-34.

123. Spaander MCW. Endoscopic Grading of Gastric Intestinal Metaplasia: Can We Do It without Pathologists? Endoscopy. 2019;51(6):509-10.

124. Spaander MCW, Kuipers EJ. Effects of Oral Anticoagulant and Aspirin Use on Ability of Fecal Immunochemical Tests to Detect Advanced Neoplasia. Gastroenterology. 2019;156(6):1553-5.

125. Suker M, Koerkamp BG, Coene PP, van der Harst E, Bonsing BA, Vahrmeijer AL, Mieog JSD, Swijnenburg RJ, Dwarkasing RS, Roos D, van Eijck CHJ. Yield of Staging Laparoscopy before Treatment of Locally Advanced Pancreatic Cancer to Detect Occult Metastases. Eur J Surg Oncol. 2019;45(10):1906-11.

126. Suker M, Nuyttens JJ, Eskens F, Haberkorn BCM, Coene PLO, van der Harst E, Bonsing BA, Vahrmeijer AL, Mieog JSD, Jan Swijnenburg R, Roos D, Koerkamp BG, van Eijck CHJ. Efficacy and Feasibility of Stereotactic Radiotherapy after Folfirinox in Patients with Locally Advanced Pancreatic Cancer (Lapc-1 Trial). EClinicalMedicine. 2019;17:100200.

127. Suker M, Tovar Doncel MS, Pinto Lima AA, Ince C, van Eijck CHJ. Sublingual Microcirculation in Pancreatico-Biliary Surgery: An Observational Study. Clin Hemorheol Microcirc. 2019;72(3):247-57.

128. Suzuki L, Ten Kate FJC, Gotink AW, Stoop H, Doukas M, Nieboer D, Spaander MCW, van Lanschot JJB, van Wijnhoven BPL, Koch AD, Bruno MJ, Looijenga LHJ, Biermann K. Olfactomedin 4 (Olfm4) Expression Is Associated with Nodal Metastases in Esophageal Adenocarcinoma. PLoS One. 2019;14(7):e0219494.

129. Ten Hove JR, Shah SC, Shaffer SR, Bernstein CN, Castaneda D, Palmela C, Mooiweer E, Elman J, Kumar A, Glass J, Axelrad J, Ullman TA, Colombel JF, Torres J, van Bodegraven AA, Hoentjen F, Jansen JM, de Jong ME, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Itzkowitz SH, Oldenburg B. Consecutive Negative Findings on Colonoscopy During Surveillance Predict a Low Risk of Advanced Neoplasia in Patients with Inflammatory Bowel Disease with Long-Standing Colitis: Results of a 15-Year Multicentre, Multinational Cohort Study. Gut. 2019;68(4):615-22.

130. Ten Kate CA, Vlot J, H IJ, Allegaert K, Spaander MCW, Poley MJ, van Rosmalen J, van den Akker ELT, Wijnen RMH. Intralesional Steroid Injections to Prevent Refractory Strictures in Patients with Oesophageal Atresia: Study Protocol for an International, Multicentre Randomised Controlled Trial (Steps-Ea Trial). BMJ Open. 2019;9(12):e033030.

131. Toes-Zoutendijk E, Bonfrer JMG, Ramakers C, Thelen M, Spaander MCW, Dekker E, van der Meulen MP, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, van Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I. Quality Monitoring of a Fit-Based Colorectal Cancer Screening Program. Clin Chem. 2019;65(3):419-26.

132. Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I, Dutch National Colorectal Cancer Screening Working G. Incidence of Interval Colorectal Cancer after Negative Results from First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age. Clin Gastroenterol Hepatol. 2019.

133. Tringali A, Reddy DN, Ponchon T, Neuhaus H, Llado FG, Navarrete C, Bruno MJ, Kortan PP, Lakhtakia S, Peetermans J, Rousseau M, Carr-Locke D, Deviere J, Costamagna G, Benign Biliary Stenoses Working G. Treatment of Post-Cholecystectomy Biliary Strictures with Fully-Covered Self-Expanding Metal Stents - Results after 5 Years of Follow-Up. BMC Gastroenterol. 2019;19(1):214.

134. Ubbink R, van Dijk LJD, van Noord D, Johannes T, Specht PAC, Bruno MJ, Mik EG. Evaluation of Endoscopic Visible Light Spectroscopy: Comparison with Microvascular Oxygen Tension Measurements in a Porcine Model. J Transl Med. 2019;17(1):65.

135. Umans DS, Hallensleben ND, Verdonk RC, Bouwense SAW, Fockens P, van Santvoort HC, Voermans RP, Besselink MG, Bruno MJ, van Hooft JE, Dutch Pancreatitis Study G. Recurrence of Idiopathic Acute Pancreatitis after Cholecystectomy: Systematic Review and Meta-Analysis. Br J Surg. 2020;107(3):191-9.

136. Vale Rodrigues R, Sladek M, Katsanos K, van der Woude CJ, Wei J, Vavricka SR, Teich N, Ellul P, Savarino E, Chaparro M, Beaton D, Oliveira AM, Fragaki M, Shitrit AB, Ramos L, Karmiris K, investigators EC. Diagnosis and Outcome of Oesophageal Crohn's Disease. J Crohns Colitis. 2019.

137. Valkema MJ, Noordman BJ, Wijnhoven BPL, Spaander MCW, Biermann K, Lagarde SM, Bennink RJ, Schreurs WMJ, Roef MJ, Hobbelink MGG, Janssen MJR, Graven LH, van Lanschot JJB, Valkema R. Accuracy of (18)F-Fdg Pet/Ct in Predicting Residual Disease after Neoadjuvant Chemoradiotherapy for Esophageal Cancer. J Nucl Med. 2019;60(11):1553-9.

138. van Beek AA, Zhou G, Doukas M, Boor PPC, Noordam L, Mancham S, Campos Carrascosa L, van der Heide-Mulder M, Polak WG, Ijzermans JNM, Pan Q, Heirman C, Mahne A, Bucktrout SL, Bruno MJ, Sprengers D, Kwekkeboom J. Gitr Ligation Enhances Functionality of Tumor-Infiltrating T Cells in Hepatocellular Carcinoma. Int J Cancer. 2019;145(4):1111-24.

139. van Campenhout MJH, Brouwer WP, Xie Q, Guo S, Chi H, Qi X, Tabak F, Streinu-Cercel A, Wang JY, Zhang NP, Idilman R, Reesink HW, Diculescu M, Simon K, Akdogan M, Mazur W, de Knegt RJ, Verhey E, Hansen BE, Janssen HLA, Group AS. Long-Term Follow-up of Patients Treated with Entecavir and Peginterferon Add-on Therapy for Hbeag-Positive Chronic Hepatitis B Infection: Ares Long-Term Follow-Up. J Viral Hepat. 2019;26(1):109-17.

140. van Campenhout MJH, Rijckborst V, Brouwer WP, van Oord GW, Ferenci P, Tabak F, Akdogan M, Pinarbasi B, Simon K, de Knegt RJ, Boonstra A, Janssen HLA, Hansen BE. Hepatitis B Core-Related Antigen Monitoring During Peginterferon Alfa Treatment for Hbeag-Negative Chronic Hepatitis B. J Viral Hepat. 2019;26(10):1156-63.

141. van de Ven S, Bugter O, Hardillo JA, Bruno MJ, Baatenburg de Jong RJ, Koch AD. Screening for Head and Neck Second Primary Tumors in Patients with Esophageal Squamous Cell Cancer: A Systematic Review and Meta-Analysis. United European Gastroenterol J. 2019;7(10):1304-11.

142. van de Ven S, Leliveld L, Klimek M, Hilkemeijer T, Bruno MJ, Koch AD. Propofol Sedation without Endotracheal Intubation Is Safe for Endoscopic Submucosal Dissection in the Esophagus and Stomach. United European Gastroenterol J. 2019;7(3):405-11.

143. van den Brand FF, van der Veen KS, de Boer YS, van Gerven NM, Lissenberg-Witte BI, Beuers U, van Erpecum KJ, van Buuren HR, den Ouden JW, Brouwer JT, Vrolijk JM, Verdonk RC, van Hoek B, Koek GH, Drenth JPH, Guichelaar MMJ, Mulder CJJ, Bloemena E, van Nieuwkerk CMJ, Bouma G, Dutch Autoimmune Hepatitis Study G. Increased Mortality among Patients with Vs without Cirrhosis and Autoimmune Hepatitis. Clin Gastroenterol Hepatol. 2019;17(5):940-7 e2.

144. van den Brink G, Stapersma L, Bom AS, Rizopolous D, van der Woude CJ, Stuyt RJL, Hendriks DM, van der Burg JAT, Beukers R, Korpershoek TA, Theuns-Valks SDM, Utens E, Escher JC. Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults with Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial. Inflamm Bowel Dis. 2019;25(12):1945-56.

145. van den Brink G, van Gaalen MAC, de Ridder L, van der Woude CJ, Escher JC. Health Care Transition Outcomes in Inflammatory Bowel Disease: A Multinational Delphi Study. J Crohns Colitis. 2019;13(9):1163-72.

146. van den Brink G, van Gaalen MAC, Zijlstra M, de Ridder L, van der Woude CJ, Escher JC. Self-Efficacy Did Not Predict the Outcome of the Transition to Adult Care in Adolescents with Inflammatory Bowel Disease. Acta Paediatr. 2019;108(2):333-8.

147. van der Bogt RD, Noordman BJ, Krishnadath KK, Roumans CAM, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, van Lanschot JJB, Spaander MCW. Endoscopic Ultrasound Measurements for Detection of Residual Disease after Neoadjuvant Chemoradiotherapy for Esophageal Cancer. Endoscopy. 2019;51(4):326-32.

148. van der Bogt RD, van der Wilk BJ, Poley JW, Krishnadath KK, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, Bruno MJ, Biermann K, van Lanschot JJB, Spaander MCW. Endoscopic Ultrasound and Fine-Needle Aspiration for the Detection of Residual Nodal Disease after Neoadjuvant Chemoradiotherapy for Esophageal Cancer. Endoscopy. 2019.

149. van der Giessen J, Binyamin D, Belogolovski A, Frishman S, Tenenbaum-Gavish K, Hadar E, Louzoun Y, Peppelenbosch MP, van der Woude CJ, Koren O, Fuhler GM. Modulation of Cytokine Patterns and Microbiome During Pregnancy in Ibd. Gut. 2019.

150. van der Giessen J, Huang VW, van der Woude CJ, Fuhler GM. Modulatory Effects of Pregnancy on Inflammatory Bowel Disease. Clin Transl Gastroenterol. 2019;10(3):e00009.

151. van der Giessen J, van der Woude CJ, Peppelenbosch MP, Fuhler GM. A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models. Cells. 2019;8(3).

152. van der Giessen J, Wieringa JW, Kanis SL, van der Woude CJ. Health-Related Quality of Life in the First 5years of the Children Born to Mothers with Ibd Does Not Differ from Children Born to Healthy Mothers. J Psychosom Res. 2019;127:109840.

153. van der Sijde F, Vietsch EE, Mustafa DAM, Besselink MG, Groot Koerkamp B, van Eijck CHJ. Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients. Cancers (Basel). 2019;11(1).

154. van der Veer MAA, Nangrahary N, Hesselink DA, Erler NS, Metselaar HJ, van Gelder T, Darwish Murad S. High Intrapatient Variability in Tacrolimus Exposure Is Not Associated with Immune-Mediated Graft Injury after Liver Transplantation. Transplantation. 2019;103(11):2329-37.

155. van der Wiel SE, Koch AD, Bruno MJ. Face Validity of a Synthetic Papilla Designed for Biliary Sphincterotomy Training. Endosc Int Open. 2019;7(6):E757-E61.

156. van der Wiel SE, Poley JW, Koch AD, Bruno MJ. Endoscopic Resection of Advanced Ampullary Adenomas: A Single-Center 14-Year Retrospective Cohort Study. Surg Endosc. 2019;33(4):1180-8.

157. van der Wilk BJ, Eyck BM, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB. Towards an Organ-Sparing Approach for Locally Advanced Esophageal Cancer. Dig Surg. 2019;36(6):462-9.

158. van der Wilk BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, Nieuwenhuijzen GAP, Sosef MN, van Berge Henegouwen MI, Lagarde SM, Spaander MCW, Valkema R, Biermann K, Wijnhoven BPL, van der Gaast A, van Lanschot JJB, Doukas M, Nikkessen S, Luyer M, Schoon EJ, Roef MJ, van Lijnschoten I, Oostenbrug LE, Riedl RG, Gisbertz SS, Krishnadath KK, Bennink RJ, Meijer SL, Collaborators. Active Surveillance Versus Immediate Surgery in Clinically Complete Responders after Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study. Ann Surg. 2019.

159. van der Woude CJ, Shitrit AB. Pregnancy, Psychiatry and Ibd: Multidisciplinary Care Is Crucial. Nat Rev Gastroenterol Hepatol. 2019;16(5):265-6.

160. van Dijk LJ, van Noord D, de Vries AC, Kolkman JJ, Geelkerken RH, Verhagen HJ, Moelker A, Bruno MJ. Clinical Management of Chronic Mesenteric Ischemia. United European Gastroenterol J. 2019;7(2):179-88.

161. van Dijk LJ, van Noord D, Geelkerken RH, Harki J, Berendsen SA, de Vries AC, Moelker A, Vergouwe Y, Verhagen HJ, Kolkman JJ, Bruno MJ, Dutch Mesenteric Ischemia Study g. Validation of a Score Chart to Predict the Risk of Chronic Mesenteric Ischemia and Development of an Updated Score Chart. United European Gastroenterol J. 2019;7(9):1261-70.

162. van Dijk LJD, Harki J, van Noord D, de Vries AC, Moelker A, Verhagen HJM, Kuipers EJ, Bruno MJ. Detection of Mesenteric Ischemia by Means of Endoscopic Visible Light Spectroscopy after Luminal Feeding. Gastrointest Endosc. 2019;89(1):94-102.

163. van Dijk LJD, Harki J, van Noord D, Verhagen HJM, Kolkman JJ, Geelkerken RH, Bruno MJ, Moelker A, Dutch Mesenteric Ischemia Study g. Covered Stents Versus Bare-Metal Stents in Chronic Atherosclerotic Gastrointestinal Ischemia (Cobagi): Study Protocol for a Randomized Controlled Trial. Trials. 2019;20(1):519.

164. van Dijk LJD, Ubbink R, Terlouw LG, van Noord D, Mik EG, Bruno MJ. Oxygen-Dependent Delayed Fluorescence of Protoporphyrin Ix Measured in the Stomach and Duodenum During Upper Gastrointestinal Endoscopy. J Biophotonics. 2019;12(10):e201900025.

165. van Dijk LJD, van Noord D, van Mierlo M, Bijdevaate DC, Bruno MJ, Moelker A. Single-Center Retrospective Comparative Analysis of Transradial, Transbrachial, and Transfemoral Approach for Mesenteric Arterial Procedures. J Vasc Interv Radiol. 2020;31(1):130-8.

166. van Dijk SM, Timmerhuis HC, Verdonk RC, Reijnders E, Bruno MJ, Fockens P, Voermans RP, Besselink MG, van Santvoort HC, Dutch Pancreatitis Study G. Treatment of Disrupted and Disconnected Pancreatic Duct in Necrotizing Pancreatitis: A Systematic Review and Meta-Analysis. Pancreatology. 2019;19(7):905-15.

167. van Grinsven J, van Dijk SM, Dijkgraaf MG, Boermeester MA, Bollen TL, Bruno MJ, van Brunschot S, Dejong CH, van Eijck CH, van Lienden KP, Boerma D, van Duijvendijk P, Hadithi M, Haveman JW, van der Hulst RW, Jansen JM, Lips DJ, Manusama ER, Molenaar IQ, van der Peet DL, Poen AC, Quispel R, Schaapherder AF, Schoon EJ, Schwartz MP, Seerden TC, Spanier BWM, Straathof JW, Venneman NG, van de Vrie W, Witteman BJ, van Goor H, Fockens P, van Santvoort HC, Besselink MG, Dutch Pancreatitis Study G. Postponed or Immediate Drainage of Infected Necrotizing Pancreatitis (Pointer Trial): Study Protocol for a Randomized Controlled Trial. Trials. 2019;20(1):239.

168. van Halewijn GJ, Geurtsvankessel CH, Klaasse J, van Oord GW, de Knegt RJ, van Campenhout MJ, Boonstra A, van der Eijk AA. Diagnostic and Analytical Performance of the Hepatitis B Core Related Antigen Immunoassay in Hepatitis B Patients. J Clin Virol. 2019;114:1-5.

169. van Keulen KE, Neumann H, Schattenberg JM, van Esch AAJ, Kievit W, Spaander MCW, Siersema PD. A Novel Device for Intracolonoscopy Cleansing of Inadequately Prepared Colonoscopy Patients: A Feasibility Study. Endoscopy. 2019;51(1):85-92.

170. van Mackelenbergh MG, Stroes CI, Spijker R, van Eijck CHJ, Wilmink JW, Bijlsma MF, van Laarhoven HWM. Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel). 2019;11(5).

171. van Riet PA, Cahen DL, Biermann K, Hansen B, Larghi A, Rindi G, Fellegara G, Arcidiacono P, Doglioni C, Liberta Decarli N, Iglesias-Garcia J, Abdulkader I, Lazare Iglesias H, Kitano M, Chikugo T, Yasukawa S, van der Valk H, Nguyen NQ, Ruszkiewicz A, Giovannini M, Poizat F, van der Merwe S, Roskams T, Santo E, Marmor S, Chang K, Lin F, Farrell J, Robert M, Bucobo JC, Heimann A, Baldaque-Silva F, Fernandez Moro C, Bruno MJ. Agreement on Endoscopic Ultrasonography-Guided Tissue Specimens: Comparing a 20-G Fine-Needle Biopsy to a 25-G Fine-Needle Aspiration Needle among Academic and Non-Academic Pathologists. Dig Endosc. 2019;31(6):690-7.

172. van Riet PA, Giorgio Arcidiacono P, Petrone M, Quoc Nguyen N, Kitano M, Chang K, Larghi A, Iglesias-Garcia J, Giovannini M, van der Merwe S, Santo E, Baldaque-Silva F, Bucobo JC, Bruno MJ, Aslanian HR, Cahen DL, Farrell J. Combined Versus Single Use 20 G Fine-Needle Biopsy and 25 G Fine-Needle Aspiration for Endoscopic Ultrasound-Guided Tissue Sampling of Solid Gastrointestinal Lesions. Endoscopy. 2020;52(1):37-44.

173. van Riet PA, Larghi A, Attili F, Rindi G, Nguyen NQ, Ruszkiewicz A, Kitano M, Chikugo T, Aslanian H, Farrell J, Robert M, Adeniran A, Van Der Merwe S, Roskams T, Chang K, Lin F, Lee JG, Arcidiacono PG, Petrone M, Doglioni C, Iglesias-Garcia J, Abdulkader I, Giovannini M, Bories E, Poizat F, Santo E, Scapa E, Marmor S, Bucobo JC, Buscaglia JM, Heimann A, Wu M, Baldaque-Silva F, Moro CF, Erler NS, Biermann K, Poley JW, Cahen DL, Bruno MJ. A Multicenter Randomized Trial Comparing a 25-Gauge Eus Fine-Needle Aspiration Device with a 20-Gauge Eus Fine-Needle Biopsy Device. Gastrointest Endosc. 2019;89(2):329-39.

174. van Rosmalen BV, Klompenhouwer AJ, de Graeff JJ, Haring MPD, de Meijer VE, Rifai L, Dokmak S, Rawashdeh A, Abu Hilal M, de Jong MC, Dejong CHC, Doukas M, de Man RA, JNM IJ, van Delden OM, Verheij J, van Gulik TM, Dutch Benign Liver Tumour G. Safety and Efficacy of Transarterial Embolization of Hepatocellular Adenomas. Br J Surg. 2019;106(10):1362-71.

175. van Seyen M, Smolders EJ, van Wijngaarden P, Drenth JPH, Wouthuyzen-Bakker M, de Knegt RJ, Honkoop P, El-Sherif O, Colbers A, Back DJ, Burger DM. Successful Hcv Treatment of Patients on Contraindicated Anti-Epileptic Drugs: Role of Drug Level Monitoring. J Hepatol. 2019;70(3):552-4.

176. Vanhooymissen I, Thomeer MG, Braun LMM, Gest B, van Koeverden S, Willemssen FE, Hunink M, De Man RA, Ijzermans JN, Dwarkasing RS. Intrapatient Comparison of the Hepatobiliary Phase of Gd-Bopta and Gd-Eob-Dtpa in the Differentiation of Hepatocellular Adenoma from Focal Nodular Hyperplasia. J Magn Reson Imaging. 2019;49(3):700-10.

177. Vergouwe FWT, van Wijk MP, Spaander MCW, Bruno MJ, Wijnen RMH, Schnater JM, H IJ. Evaluation of Gastroesophageal Reflux in Children Born with Esophageal Atresia Using Ph and Impedance Monitoring. J Pediatr Gastroenterol Nutr. 2019;69(5):515-22.

178. Vergouwe FWT, Vlot J, H IJ, Spaander MCW, van Rosmalen J, Oomen MWN, Hulscher JBF, Dirix M, Bruno MJ, Schurink M, Wijnen RMH, Group DS. Risk Factors for Refractory Anastomotic Strictures after Oesophageal Atresia Repair: A Multicentre Study. Arch Dis Child. 2019;104(2):152-7.

179. Vermeulen BD, Reijm AN, van der Bogt RD, van Hooft JE, Spaander MCW, Siersema PD. Through-the-Scope Placement of a Fully Covered Metal Stent for Palliation of Malignant Dysphagia: A Prospective Cohort Study (with Video). Gastrointest Endosc. 2019;90(6):972-9.

180. von Felden J, Alric L, Pischke S, Aitken C, Schlabe S, Spengler U, Giordani MT, Schnitzler P, Bettinger D, Thimme R, Xhaard A, Binder M, Ayuk F, Lohse AW, Cornelissen JJ, de Man RA, Mallet V. The Burden of Hepatitis E among Patients with Haematological Malignancies: A Retrospective European Cohort Study. J Hepatol. 2019;71(3):465-72.

181. Weersink RA, Taxis K, Drenth JPH, Houben E, Metselaar HJ, Borgsteede SD. Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study. Drug Saf. 2019;42(4):539-46.

182. Weersink RA, Timmermans L, Monster-Simons MH, Mol PGM, Metselaar HJ, Borgsteede SD, Taxis K. Evaluation of Information in Summaries of Product Characteristics (Smpcs) on the Use of a Medicine in Patients with Hepatic Impairment. Front Pharmacol. 2019;10:1031.

183. Wieringa JW, van der Woude CJ. Editorial: The Effect of Thiopurines on Offspring. J Crohns Colitis. 2019;13(1):1-2.

184. Wieten E, de Klerk CM, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW. A Quarter of Participants with Advanced Neoplasia Have Discordant Results from 2-Sample Fecal Immunochemical Tests for Colorectal Cancer Screening. Clin Gastroenterol Hepatol. 2019.

185. Wieten E, Schreuders EH, Grobbee EJ, Nieboer D, Bramer WM, Lansdorp-Vogelaar I, Bruno MJ, Kuipers EJ, Spaander MCW.

186. Incidence of Faecal Occult Blood Test Interval Cancers in Population-Based Colorectal Cancer Screening: A Systematic Review and Meta-Analysis. Gut. 2019;68(5):873-81.

187. Zhou G, Sprengers D, Mancham S, Erkens R, Boor PPC, van Beek AA, Doukas M, Noordam L, Campos Carrascosa L, de Ruiter V, van Leeuwen RWF, Polak WG, de Jonge J, Groot Koerkamp B, van Rosmalen B, van Gulik TM, Verheij J, JNM IJ, Bruno MJ, Kwekkeboom J. Reduction of Immunosuppressive Tumor Microenvironment in Cholangiocarcinoma by Ex Vivo Targeting Immune Checkpoint Molecules. J Hepatol. 2019;71(4):753-62.

​